Family Health Centers of San Diego, INC
Family Health Centers of San Diego, INC was paid $47.86M by Medicaid between Jan 2018 and Nov 2024, across 223 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 99% of everything it billed.
CHULA VISTA, CA 91910
Next to other Federally Qualified Health Center (FQHC) providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 48,741 | $6.45M | |
| 2019 | 76,188 | $5.95M | |
| 2020 | 143,244 | $8.67M | |
| 2021 | 149,932 | $8.67M | |
| 2022 | 109,153 | $6.88M | |
| 2023 | 138,167 | $8.58M | |
| 2024incomplete | 36,283 | $2.65M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 99% | 287,158 | 197,025 | $47.53M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 6,605 | 3,348 | $73K |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | <1% | 5,549 | 4,012 | $37K |
| G0467 | Community health center visit, returning patientFederally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | <1% | 1,285 | 1,132 | $34K |
| 0013A | <1% | 316 | 315 | $21K | |
| 0004A | <1% | 309 | 309 | $20K | |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | <1% | 292 | 250 | $18K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,730 | 962 | $15K |
| 0002A | <1% | 216 | 210 | $14K | |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | <1% | 1,483 | 1,369 | $13K |
| 0001A | <1% | 172 | 166 | $11K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 51,143 | 45,288 | $9K |
211 more codes
| 98940 | <1% | 1,815 | $8K | |
| 0124A | <1% | 125 | $8K | |
| 0134A | <1% | 108 | $7K | |
| 97161 | <1% | 163 | $6K | |
| 0012A | <1% | 56 | $4K | |
| G9920 | Screening performed and negative | <1% | 547 | $4K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 35,398 | $3K |
| 0071A | <1% | 52 | $3K | |
| 96156 | <1% | 124 | $3K | |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 209 | $2K |
| 0011A | <1% | 48 | $2K | |
| 97162 | <1% | 538 | $1K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 251 | $1K |
| 98942 | <1% | 233 | $1K | |
| 80061 | Lipid panel | <1% | 8,515 | $1K |
| 0072A | <1% | 18 | $1K | |
| 90686 | <1% | 4,591 | $1K | |
| 98960 | <1% | 1,272 | $1K | |
| 80053 | Comprehensive metabolic panel | <1% | 9,121 | $885.87 |
| 0003A | <1% | 12 | $804.00 | |
| 90630 | <1% | 36 | $786.00 | |
| H1003 | Prenatal care, at-risk enhanced service; education | <1% | 44 | $639.58 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 7,605 | $595.98 |
| 97803 | <1% | 7,683 | $496.61 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 11,415 | $458.48 |
| 90688 | <1% | 270 | $440.00 | |
| 90756 | <1% | 1,577 | $249.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 7,030 | $241.53 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 13,043 | $218.85 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,019 | $179.70 |
| 99401 | <1% | 767 | $167.02 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 8,845 | $111.98 |
| 81002 | <1% | 9,520 | $96.53 | |
| 97164 | <1% | 294 | $94.14 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 4,609 | $13.26 |
| 86803 | <1% | 2,038 | $12.57 | |
| 86704 | <1% | 1,461 | $10.83 | |
| 96127 | <1% | 3,046 | $9.62 | |
| 86706 | <1% | 1,580 | $9.51 | |
| 87340 | <1% | 591 | $9.12 | |
| 90670 | <1% | 2,356 | $8.92 | |
| 90698 | <1% | 1,418 | $8.92 | |
| 84460 | <1% | 1,310 | $4.58 | |
| 90633 | <1% | 1,333 | $4.46 | |
| 84450 | <1% | 1,316 | $4.41 | |
| 99000 | <1% | 5,265 | $3.63 | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 0% | 1,315 | $0.00 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 1,880 | $0.00 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 253 | $0.00 |
| X3904 | 0% | 12,717 | $0.00 | |
| 92553 | 0% | 201 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 2,919 | $0.00 |
| 90715 | 0% | 1,846 | $0.00 | |
| 81003 | 0% | 3,796 | $0.00 | |
| 83540 | 0% | 651 | $0.00 | |
| 82570 | 0% | 1,158 | $0.00 | |
| 90734 | 0% | 510 | $0.00 | |
| 99173 | 0% | 4,844 | $0.00 | |
| Z6400 | 0% | 3,028 | $0.00 | |
| Z6200 | 0% | 826 | $0.00 | |
| 86708 | 0% | 107 | $0.00 | |
| 87210 | 0% | 1,642 | $0.00 | |
| 11721 | 0% | 526 | $0.00 | |
| 2028F | 0% | 1,531 | $0.00 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 0% | 2,690 | $0.00 |
| Z6304 | 0% | 973 | $0.00 | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 0% | 2,022 | $0.00 |
| 84439 | 0% | 190 | $0.00 | |
| 90461 | 0% | 2,896 | $0.00 | |
| 99204 | Doctor's office visit, new patient (more involved) | 0% | 445 | $0.00 |
| V2020 | Frames, purchases | 0% | 1,500 | $0.00 |
| 81025 | 0% | 4,495 | $0.00 | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 0% | 2,866 | $0.00 |
| 90648 | 0% | 139 | $0.00 | |
| 85007 | 0% | 487 | $0.00 | |
| 82947 | 0% | 1,008 | $0.00 | |
| 90681 | 0% | 122 | $0.00 | |
| 86480 | 0% | 2,029 | $0.00 | |
| 90746 | 0% | 273 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 94 | $0.00 |
| 90707 | 0% | 580 | $0.00 | |
| Z6308 | 0% | 51 | $0.00 | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 0% | 939 | $0.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 3,597 | $0.00 |
| Z6500 | 0% | 16 | $0.00 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 0% | 2,415 | $0.00 |
| 90700 | 0% | 576 | $0.00 | |
| 99201 | 0% | 571 | $0.00 | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 0% | 2,809 | $0.00 |
| 90832 | Psychotherapy session, about 30 minutes | 0% | 420 | $0.00 |
| Z6300 | 0% | 811 | $0.00 | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 0% | 533 | $0.00 |
| 92015 | Determination of refractive state | 0% | 3,308 | $0.00 |
| 85610 | 0% | 853 | $0.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 4,692 | $0.00 |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 0% | 331 | $0.00 |
| 99404 | 0% | 1,348 | $0.00 | |
| 80354 | 0% | 43 | $0.00 | |
| 92133 | 0% | 57 | $0.00 | |
| 99203 | Doctor's office visit, new patient (routine) | 0% | 989 | $0.00 |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | 0% | 1,160 | $0.00 |
| 96160 | 0% | 1,777 | $0.00 | |
| 90750 | 0% | 949 | $0.00 | |
| 59025 | Fetal non-stress test | 0% | 248 | $0.00 |
| 90714 | 0% | 12 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 678 | $0.00 |
| 90710 | 0% | 167 | $0.00 | |
| 92341 | 0% | 278 | $0.00 | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | 0% | 673 | $0.00 |
| 91312 | 0% | 59 | $0.00 | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 0% | 14 | $0.00 |
| 90713 | 0% | 65 | $0.00 | |
| 82248 | 0% | 31 | $0.00 | |
| 82247 | 0% | 36 | $0.00 | |
| 83718 | 0% | 33 | $0.00 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 0% | 687 | $0.00 |
| Z6414 | 0% | 96 | $0.00 | |
| 82274 | 0% | 43 | $0.00 | |
| 3078F | 0% | 90 | $0.00 | |
| 91313 | 0% | 20 | $0.00 | |
| 82465 | 0% | 33 | $0.00 | |
| 2022F | 0% | 28 | $0.00 | |
| 84550 | 0% | 14 | $0.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 14 | $0.00 |
| Z6402 | 0% | 884 | $0.00 | |
| 87081 | 0% | 832 | $0.00 | |
| A9300 | Exercise equipment | 0% | 310 | $0.00 |
| 82951 | 0% | 1,141 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 8,056 | $0.00 |
| 85651 | 0% | 1,092 | $0.00 | |
| 91301 | 0% | 28 | $0.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 3,277 | $0.00 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 3,547 | $0.00 |
| 86592 | 0% | 3,274 | $0.00 | |
| 90716 | 0% | 621 | $0.00 | |
| 58300 | 0% | 26 | $0.00 | |
| Z1034 | 0% | 10,538 | $0.00 | |
| 90744 | 0% | 1,051 | $0.00 | |
| Z6204 | 0% | 1,334 | $0.00 | |
| 92551 | 0% | 4,640 | $0.00 | |
| 81015 | 0% | 3,223 | $0.00 | |
| X3908 | 0% | 875 | $0.00 | |
| 85018 | 0% | 5,426 | $0.00 | |
| 90732 | 0% | 199 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 2,674 | $0.00 |
| 93000 | 0% | 723 | $0.00 | |
| 81001 | 0% | 580 | $0.00 | |
| X3906 | 0% | 699 | $0.00 | |
| 94760 | 0% | 1,234 | $0.00 | |
| Z6410 | 0% | 1,613 | $0.00 | |
| 92250 | 0% | 2,408 | $0.00 | |
| 82043 | 0% | 994 | $0.00 | |
| 90651 | 0% | 1,084 | $0.00 | |
| 97802 | 0% | 1,943 | $0.00 | |
| 99406 | 0% | 632 | $0.00 | |
| 83550 | 0% | 539 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 140 | $0.00 |
| 87070 | 0% | 1,912 | $0.00 | |
| Z1038 | 0% | 462 | $0.00 | |
| 82728 | 0% | 645 | $0.00 | |
| 87428 | 0% | 1,499 | $0.00 | |
| 99402 | 0% | 398 | $0.00 | |
| 86140 | 0% | 433 | $0.00 | |
| X3924 | 0% | 6,196 | $0.00 | |
| Z6406 | 0% | 561 | $0.00 | |
| 99381 | 0% | 750 | $0.00 | |
| Z1032 | 0% | 609 | $0.00 | |
| 86769 | 0% | 92 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 659 | $0.00 |
| 90697 | 0% | 552 | $0.00 | |
| 97010 | 0% | 35 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 1,975 | $0.00 |
| 90680 | 0% | 1,509 | $0.00 | |
| 87536 | 0% | 28 | $0.00 | |
| 90739 | 0% | 271 | $0.00 | |
| 90677 | 0% | 465 | $0.00 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 0% | 1,067 | $0.00 |
| 90619 | 0% | 244 | $0.00 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 0% | 141 | $0.00 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 0% | 94 | $0.00 |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 0% | 189 | $0.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 97 | $0.00 |
| H0001 | Alcohol and/or drug assessment | 0% | 81 | $0.00 |
| 2023F | 0% | 476 | $0.00 | |
| 36416 | 0% | 506 | $0.00 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 137 | $0.00 |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 0% | 2,472 | $0.00 |
| 90674 | 0% | 1,083 | $0.00 | |
| 92002 | 0% | 65 | $0.00 | |
| 99385 | 0% | 152 | $0.00 | |
| 84153 | 0% | 13 | $0.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 60 | $0.00 |
| 99459 | 0% | 140 | $0.00 | |
| 93922 | 0% | 90 | $0.00 | |
| 90620 | 0% | 13 | $0.00 | |
| 87522 | Neg quan hep c or qual rna | 0% | 44 | $0.00 |
| 80050 | General health panel | 0% | 87 | $0.00 |
| 86580 | 0% | 42 | $0.00 | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 0% | 120 | $0.00 |
| 99386 | 0% | 13 | $0.00 | |
| X3910 | 0% | 83 | $0.00 | |
| X3902 | 0% | 16 | $0.00 | |
| 83690 | 0% | 30 | $0.00 | |
| X4304 | 0% | 77 | $0.00 | |
| 90694 | 0% | 81 | $0.00 | |
| G8433 | Screening for depression not completed, documented patient or medical reason | 0% | 15 | $0.00 |
| 91200 | 0% | 14 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 12 | $0.00 |
| 3074F | 0% | 92 | $0.00 | |
| 90696 | 0% | 36 | $0.00 | |
| 3008F | 0% | 90 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.